BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2430825)

  • 1. Corynebacterium parvum in malignant pleural effusion. A randomized prospective study.
    Hillerdal G; Kiviloog J; Nöu E; Steinholtz L
    Eur J Respir Dis; 1986 Sep; 69(3):204-6. PubMed ID: 2430825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline.
    Leahy BC; Honeybourne D; Brear SG; Carroll KB; Thatcher N; Stretton TB
    Eur J Respir Dis; 1985 Jan; 66(1):50-4. PubMed ID: 3979476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring natural killer cell activity in the blood of patients with malignant pleural effusion after intrapleural administration of Corynebacterium parvum].
    Marel M; Pospísil M; Fiserová A; Melínová L; Skácel Z; Bednár M
    Cas Lek Cesk; 1990 Apr; 129(16):498-500. PubMed ID: 2340567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current treatment strategy in malignant pleural effusion].
    Türler A; Walter M; Schmitz-Rixen T
    Wien Klin Wochenschr; 1996; 108(9):255-61. PubMed ID: 8686317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the effectiveness and adverse effects of a Corynebacterium parvum vaccine made in Czechoslovakia with Coparvax, a British preparation made by Wellcome, in the treatment of malignant pleural effusions].
    Marel M; Melínová L; Bednár M
    Cas Lek Cesk; 1989 Aug; 128(34):1071-4. PubMed ID: 2790915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of intracavitary bleomycin and Corynebacterium parvum in the control of malignant pleural effusions.
    Ostrowski MJ; Priestman TJ; Houston RF; Martin WM
    Radiother Oncol; 1989 Jan; 14(1):19-26. PubMed ID: 2467327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pleural effusion. Local treatment by Corynebacterium parvum].
    Serrou B; Cupissol D
    Nouv Presse Med; 1980 Jun; 9(25):1777-8. PubMed ID: 7383874
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of efficacy of mitomycin-C and corynebacterium parvum in the management of malignant pleural effusion.
    Yew WW; Chan SL; Kwan SY
    Chin Med J (Engl); 1988 Oct; 101(10):737-9. PubMed ID: 3150706
    [No Abstract]   [Full Text] [Related]  

  • 9. Coparvax for malignant effusion?
    Drug Ther Bull; 1983 Oct; 21(20):79-80. PubMed ID: 6641514
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of Corynebacterium parvum in pleurodesis].
    Helin T; Haahtela T
    Duodecim; 1988; 104(4):262-5. PubMed ID: 3168834
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of malignant pleural effusion with drainage, with and without instillation of talc.
    Sørensen PG; Svendsen TL; Enk B
    Eur J Respir Dis; 1984 Feb; 65(2):131-5. PubMed ID: 6365578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chest drainage combined with intracavitary therapy in neoplastic pleural effusion: comparison of three different protocols].
    D'Angelo P; Sacco R; Romessis M; Mucilli F
    G Chir; 1993 Jul; 14(6):309-12. PubMed ID: 8398623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged fever after pleural instillation of Corynebacterium parvum (Coparvax).
    Laroche CM; Britton M
    Thorax; 1987 Oct; 42(10):823-4. PubMed ID: 3424259
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of neoplastic pleural effusion by intrapleural administration of Corynebacterium parvum vaccine].
    Krasucka-Kluźniak A; Krakówka P
    Pneumonol Pol; 1985 May; 53(5):240-7. PubMed ID: 4047949
    [No Abstract]   [Full Text] [Related]  

  • 15. Corynebacterium parvum pleurodesis and survival is not significantly influenced by pleural pH and glucose level.
    Bilaçeroğlu S; Cağirici U; Perim K; Ozacar R
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):14-22. PubMed ID: 9632902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapleural Corynebacterium parvum for recurrent malignant pleural effusions.
    Foresti V
    Respiration; 1995; 62(1):21-6. PubMed ID: 7716350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
    Chella A; Ribechini A; Dini P; Adamo C; Mussi A; Angeletti CA
    Minerva Chir; 1994 Nov; 49(11):1077-82. PubMed ID: 7708227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mepacrine hydrochloride in the treatment of malignant pleural effusion. A controlled randomized trial.
    Mejer J; Mortensen KM; Hansen HH
    Scand J Respir Dis; 1977 Dec; 58(6):319-23. PubMed ID: 415356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further experience of Corynebacterium parvum in malignant pleural effusion.
    McLeod DT; Calverley PM; Millar JW; Horne NW
    Thorax; 1985 Jul; 40(7):515-8. PubMed ID: 4035618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
    Stefani A; Natali P; Casali C; Morandi U
    Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.